Guru Ownership Trend
Guru Analysis for ANI Pharmaceuticals, Inc. (ANIP)
ANI Pharmaceuticals, Inc. (ANIP), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $18.53 M.
Top institutional holders include HOTCHKIS & WILEY and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $1.1 M net inflow during the quarter.
Recent activity highlights HOTCHKIS & WILEY who increased their stake by 141.7%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 71.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for ANI Pharmaceuticals, Inc. (ANIP)
Major holders include HOTCHKIS & WILEY ($14.82 M), Cliff Asness ($2.08 M), Renaissance Technologies (RenTech) ($1.31 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 259,330 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.1 M, with 2 managers increasing positions and 5 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 3 fully exited ANIP. The total reported sell value was $7.78 M.
Yes, 0 managers opened new positions in ANIP, and 2 increased their existing holdings. The total reported buy value was $8.88 M.